nagourney, page-7

re: sbp cash position Hey Olenga , I have believed the "story" from the start due to some personal knowledge of the SBPs effects . But a clinical trial is not a story , it is hard fact . SBP in tiny dosage has caused some measurable positive response including tumour shrinkage in solid cancers during phase 1 clinical trials at Sir Charles Gardiner Hospital in Perth . According to Steve Carters recent interview and newspaper reports . Also what you must remember is that the effects seen so far are from patients in the early part of the trial . There should be better results emerging from the tail end of the trial as dosage is increased . Hard to imagine it is just a first phase 1 safety trial .
Rational Therapeutics in L.A. are already doing the prelim tests to identify ideal targets for phase 2 . This stock is going to fly IMHO , and a lot sooner than 18 months .
Regarding the cash , not sure exactly what they have on hand , but this co has a very lean burn rate .
Cheers .